Merck And Co
Merck & Co., Inc., commonly referred to as Merck, is a leading global healthcare company headquartered in the United States. Founded in 1891, Merck has established itself as a pioneer in the pharmaceutical industry, focusing on innovative medicines, vaccines, and biologic therapies. With a strong presence in North America, Europe, and Asia, the company is dedicated to improving health outcomes worldwide. Merck's core products include groundbreaking treatments in oncology, infectious diseases, and vaccines, notably the HPV vaccine Gardasil and the cancer immunotherapy Keytruda. These offerings are distinguished by their commitment to research and development, which has led to numerous key milestones in medical advancements. As a market leader, Merck consistently ranks among the top pharmaceutical companies globally, recognised for its contributions to public health and its robust pipeline of future therapies.
DitchCarbon Score
How does Merck And Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Merck And Co's score of 38 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Merck And Co's reported carbon emissions
In 2023, Merck & Co. reported total carbon emissions of approximately 7,527,700,000 kg CO2e. This figure includes emissions from all three scopes: Scope 1 emissions were about 718,400,000 kg CO2e, while Scope 2 emissions (market-based) totalled approximately 184,200,000 kg CO2e. The company's Scope 3 emissions were significant, amounting to around 6,625,100,000 kg CO2e, which includes emissions from purchased goods and services, business travel, and employee commuting, among others. Over the years, Merck has shown a trend of reducing its emissions. For instance, from 2015 to 2023, the company has decreased its Scope 1 emissions from about 869,200,000 kg CO2e to 718,400,000 kg CO2e. However, there are currently no specific reduction targets or initiatives disclosed by the company, such as those aligned with the Science Based Targets initiative (SBTi) or other climate pledges. Merck's commitment to addressing climate change is evident in its ongoing efforts to monitor and report emissions across all scopes, although further details on specific reduction strategies or targets are not available. The company operates within the pharmaceutical industry, which is increasingly focusing on sustainability and reducing carbon footprints as part of broader corporate responsibility initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 869,200,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 586,300,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 5,586,300,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merck And Co is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
